Skip to content

Effect of Green tea, Sesamum indicum L and Corylus avellans L cream on prevention striae gravidarum in nuliparus women

Effect of Green tea, Sesamum indicum L and Corylus avellans L cream on prevention striae gravidarum in nuliparus women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201606192085N18
Enrollment
150
Registered
2016-06-30
Start date
2012-12-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Striae gravidarum. Striae atrophicae

Interventions

Intervention 1: Sesamum indicum L cream group: In this group, the Sesamum indicum L cream 10% were used twice a day during the intervention period in different area of abdomen, buttocks, thigh and br
Treatment - Drugs
Sesamum indicum L cream group: In this group, the Sesamum indicum L cream 10% were used twice a day during the intervention period in different area of abdomen, buttocks, thigh and breast.
Corylus avellans L cream group: In this group, the Corylus avellans L cream 5% were used twice a day during the intervention period in different area of abdomen, buttocks, thigh and breast.
Green tea cream group: In this group, the green tea cream 3% were used twice a day during the intervention period in different area of abdomen, buttocks, thigh and breast.
Cream base group: In this group, the base of cream were used twice a day during the intervention period in different area of abdomen, buttocks, thigh and breast.
Control group: The patients in this group did not use any substance for prevention of striae.

Sponsors

Shahrekord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Gestational age of 20 weeks, singleton, aged 18 to 35 years old Exclusion criteria: Hepatic or systemic diseases, allergy to herbal components, termination of pregnancy, use of glucocorticoid drugs during the study period, lack of follow up

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of striae gravidarum. Timepoint: At the twentieth and thirty-Sixth weeks of pregnancy and after delivery (until two weeks). Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Parvin

Shahrekord University of Medical Sciences

np285@yahoo.com+98 38333335652

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026